Loading...
Market
Will Retro Biosciences receive additional funding based on GPT-4b-micro results by mid-2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Press releases or financial news outlets covering Retro Biosciences
Story
OpenAI Develops GPT-4b-Micro AI Model with Retro Biosciences to Enhance Longevity Research, Achieving 50 Times Greater Effectiveness
Jan 17, 2025, 04:00 PM
OpenAI has developed a new AI model, named GPT-4b-micro, in collaboration with Retro Biosciences, a longevity startup funded by Sam Altman. This model is designed to enhance the reprogramming of cells by providing suggestions on how to re-engineer Yamanaka factors, which are crucial for cellular reprogramming. The collaboration aims to extend human life, with the model reportedly allowing researchers to modify two of the Yamanaka factors to achieve over 50 times greater effectiveness. The initiative reflects OpenAI's broader commitment to advancing longevity science through innovative bioengineering solutions.
View original story
Similar markets
Yes • 50%
No • 50%
$50 million to $100 million • 25%
$100 million to $200 million • 25%
More than $200 million • 25%
Less than $50 million • 25%
$100 million to $200 million • 25%
Less than $100 million • 25%
More than $300 million • 25%
$200 million to $300 million • 25%
No • 50%
Yes • 50%
Microsoft • 25%
Google • 25%
Other • 25%
Amazon • 25%
Q1 2025 • 25%
Q4 2025 • 25%
Q3 2025 • 25%
Q2 2025 • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%